Therapies for ventricular cardiac arrhythmias

Critical Reviews in Biomedical Engineering

Volumn 33, Issue 6, 2005, Pages 557-604

  Jordan, Peter N ^a   Christini, David J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ablation; Defibrillation; Electrophysiology; Fibrillation; Nonlinear dynamics; Reentry

Indexed keywords

ABLATION; CARDIOVASCULAR SYSTEM; DEFIBRILLATORS; DYNAMICS; ELECTROPHYSIOLOGY; HEALTH CARE; MATHEMATICAL MODELS; PATIENT TREATMENT; REENTRY;

CLINICAL TECHNIQUES; ELECTRICAL BEHAVIOR; FIBRILLATION; VENTRICULAR CARDIAC ARRHYTHMIAS;

BIOMEDICAL ENGINEERING;

ACEBUTOLOL; ADENOSINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; DIGITOXIN; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; DOFETILIDE; ENCAINIDE; ESMOLOL; FLECAINIDE; IBUTILIDE; LIDOCAINE; MEXILETINE; MORACIZINE; PHENYTOIN; POTASSIUM CHANNEL BLOCKING AGENT; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; SOTALOL; TOCAINIDE; VERAPAMIL;

CATHETER ABLATION; DEFIBRILLATION; DEFIBRILLATOR; ELECTRIC ACTIVITY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION THERAPY; EXCITATION CONTRACTION COUPLING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; NONLINEAR SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; REVIEW; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED STATES;

EID: 33645470908     PISSN: 0278940X     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevBiomedEng.v33.i6.20     Document Type: Review

References (155)

1. American Heart Association. Heart disease and stroke statistics - 2005 update. Dallas (TX): American Heart Association; 2005.
2. Berne RM, Levy MN. Cardiovascular physiology. 8th ed. St. Louis (MO): Mosby; 2001.
3. Bers DM. Excitation-contraction coupling and cardiac contractile force. 2nd ed. Dordrecht-Boston: Kluwer Academic; 2001.
4. Schram G, Pourrier M, Melnyk P, Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res. 2002;90:939-50.
5. Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol. 2001;96:517-27.
6. Nerbonne JM, Guo W. Heterogeneous expression of voltage-gated potassium channels in the heart: roles in normal excitation and arrhythmias. J Cardiovasc Electrophysiol. 2002;13:406-9.
7. Wasson S, Reddy HK, Dohrmann ML. Current perspectives of electrical remodeling and its therapeutic implications. J Cardiovasc Pharmacol Ther. 2004;9:129-44.
8. Nolasco JB, Dahlen RW. A graphic method for the study of alternation in cardiac action potentials. J Appl Physiol. 1968;25:191-6.
9. Bass BG. Restitution of the action potential in cat papillary muscle. Am J Physiol. 1975;228:1717-24.
10. Boyett MR, Jewell BR. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophys Mol Biol. 1980;36:1-52.
11. Koller ML, Riccio ML, Gilmour RF Jr. Dynamic restitution of action potential duration during electrical alternans and ventricular fibrillation. Am J Physiol. 1998;275:H1635-42.
12. Jordan PN, Christini DJ. Determining the effects of memory and action potential duration alternans on cardiac restitution using a constant-memory restitution protocol. Physiol Meas. 2004;25:1013-24.
13. Kalb SS, Dobrovolny HM, Tolkacheva EG, Idriss SF, Krassowska W, Gauthier DJ. The restitution portrait: a new method for investigating rate-dependent restitution. J Cardiovasc Electrophysiol. 2004;15:698-709.
14. Guevara MR, Ward G, Shrier A, Glass L. Electrical alternans and period-doubling bifurcations. IEEE Comput Cardiol. 1984:167-70.
15. Henriquez AP, Vogel R, Muller-Borer BJ, Henriquez CS, Weingart R, Cascio WE. Influence of dynamic gap junction resistance on impulse propagation in ventricular myocardium: a computer simulation study. Biophys J. 2001;81:2112-21.
16. Vogel R, Weingart R. The electrophysiology of gap junctions and gap junction channels and their mathematical modelling. Biol Cell. 2002;94:501-10.
17. Lin X, Gemel J, Beyer EC, Veenstra RD. Dynamic model for ventricular junctional conductance during the cardiac action potential. Am J Physiol. 2005;288:H1113-23.
18. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res. 1997;81:727-41.
19. Banville I, Gray RA. Effect of action potential duration and conduction velocity restitution and their spatial dispersion on alternans and the stability of arrhythmias. J Cardiovasc Electrophysiol. 2002;13:1141-9.
20. Cain JW, Tolkacheva EG, Schaeffer DG, Gauthier DJ. Rate-dependent propagation of cardiac action potentials in a one-dimensional fiber. Phys Rev E. 2004;70:061906.
21. Cherry EM, Fenton FH. Suppression of alternans and conduction blocks despite steep APD restitution: electrotonic, memory, and conduction velocity restitution effects. Am J Physiol. 2004;286:H2332-41.
22. Antzelevitch C, Burashnikov A. Mechanisms of arrhythmogenesis. In: Podrid PJ, Kowey PR, editors. Cardiac arrhythmia: mechanisms, diagnosis, and management. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
23. Jalife J, Delmar M, Davidenko JM, Anumonwo JMB. Basic cardiac electrophysiology for the clinician. Armonk (NY): Futura; 1999.
24. Castellanos A, Saoudi N, Moleiro F, Myerberg RJ. Parasystole. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 4th ed. Philadelphia: Saunders; 2004.
25. Antzelevitch C. Clinical application of new concepts of parasystole, reflection, and tachycardia. Cardiol Clin. 1983;1:39-50.
26. Yan GX, Joshi A, Guo D, Hlaing T, Martin J, Xu X, Kowey PR. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation. 2004;110:1036-41.
27. Rudy Y. Reentry: insights from theoretical simulations in a fixed pathway. J Cardiovasc Electrophysiol. 1995;6:294-312.
28. Iravanian S, Nabutovsky Y, Kong CR, Saha S, Bursac N, Tung L. Functional reentry in cultured monolayers of neonatal rat cardiac cells. Am J Physiol. 2003;285:H449-56.
29. Bursac N, Aguel F, Tung L. Multiarm spirals in a two-dimensional cardiac substrate. Proc Natl Acad Sci U S A. 2004;101:15530-4.
30. Athill CA, Ikeda T, Kim YH, Wu TJ, Fishbein MC, Karagueuzian HS, Chen PS. Transmembrane potential properties at the core of functional reentrant wave fronts in isolated canine right atria. Circulation. 1998;98:1556-67.
31. Davidenko JM, Pertsov AV, Salomonsz R, Baxter W, Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle. Nature. 1992;355:349-51.
32. Myerberg RJ, Castellanos A, Huikuri HV. Origins, classification, and significance of ventricular arrhythmias. In: Spooner PM, Rosen MR, editors. Foundations of cardiac arrhythmias: basic concepts and clinical approaches. New York: Marcel Dekker; 2001.
33. El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol. 2003;18:6-13.
34. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013-22.
35. El-Sherif N, Turitto G. Torsade de Pointes. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 4th ed. Philadelphia: Saunders; 2004.
36. El-Sherif N, Caref EB, Yin H, Restivo M. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome. Tridimensional mapping of activation and recovery patterns. Circ Res. 1996;79:474-92.
37. Noble D, Cohen I. The interpretation of the T wave of the electrocardiogram. Cardiovasc Res. 1978;12:13-27.
38. Laurita KR, Girouard SD, Rosenbaum DS. Modulation of ventricular repolarization by a premature stimulus. Role of epicardial dispersion of repolarization kinetics demonstrated by optical mapping of the intact guinea pig heart. Circ Res. 1996;79:493-503.
39. Wu J, Zipes DP. Transmural reentry triggered by epicardial stimulation during acute ischemia in canine ventricular muscle. Am J Physiol. 2002;283:H2004-11.
40. Qu Z, Garfinkel A, Chen PS, Weiss JN. Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation. 2000;102:1664-70.
41. Watanabe MA, Fenton FH, Evans SJ, Hastings HM, Karma A. Mechanisms for discordant alternans. J Cardiovasc Electrophysiol. 2001;12:196-206.
42. Pastore JM, Girouard SD, Laurita KR, Akar FG, Rosenbaum DS. Mechanism linking T-wave alternans to the genesis of cardiac fibrillation. Circulation. 1999;99: 1385-94.
43. Chinushi M, Kozhevnikov D, Caref EB, Restivo M, El-Sherif N. Mechanism of discordant T wave alternans in the in vivo heart. J Cardiovasc Electrophysiol. 2003;14:632-8.
44. Fogoros RN. Electrophysiologic testing. 3rd ed. Cambridge (MA): Blackwell Science; 1999.
45. Buxton AE, Lee KL, DiCarlo L, Gold MR, Greer GS, Prystowsky EN, O'Toole MF, Tang A, Fisher JD, Coromilas J, Talajic M, Hafley G. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937-45.
46. Roden DM. Antiarrhythmic drugs: past, present, and future. Pacing Clin Electrophysiol. 2003;26:2340-9.
47. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24:129-47.
48. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med. 1989;321:406-12.
49. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. The Cardiac Arrhythmia Pilot Study (CAPS) Investigators. Am J Cardiol. 1988;61:501-9.
50. Coromilas J, Saltman AE, Waldecker B, Dillon SM, Wit AL. Electrophysiological effects of flecainide on anisotropic conduction and reentry in infarcted canine hearts. Circulation. 1995;91:2245-63.
51. Fogoros RN. Antiarrhythmic drugs: a practical guide. Cambridge (MA): Blackwell Science; 1997.
52. Smith TW, Cain ME. Class III antiarrhythmic drugs: Amiodarone, Ibutilide, and Sotalol. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 4th ed. Philadelphia: Saunders; 2004.
53. Singh BN. Beta-blockers and calcium channel blockers as antiarrhythmic drugs. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 4th ed. Philadelphia: Saunders; 2004.
54. Mirowski M, Mower MM. Transvenous automatic defibrillator as an approach to prevention of sudden death from ventricular fibrillation. Heart Lung. 1973;2:867-9.
55. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322-4.
56. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med. 2003;349:1836-47.
57. Jauhar S, Slotwiner DJ. The Economics of ICDs. N Engl J Med. 2004;351:2542-4.
58. Cannom DS, Prystowsky EN. The evolution of the implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:419-31.
59. Niebauer MJ, Wilkoff BL. Implantable cardioverter-defibrillators: technical aspects. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 3rd ed. Philadelphia: Saunders; 2000.
60. Schaumann A, von zur Muhlen F, Herse B, Gonska BD, Kreuzer H. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation. 1998;97:66-74.
61. Bardy GH, Ivey TD, Allen M, Johnson G. A prospective, randomized evaluation of effect of ventricular fibrillation duration on defibrillation thresholds in humans. J Am Coll Cardiol. 1989;13:1362-6.
62. Block M, Hammel D, Bocker D, Borggrefe M, Budde T, Isbruch F, Wietholt D, Scheld HH, Breithardt G. A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol. 1994;5:581-90.
63. Yee R, Connolly S, Noorani H. Clinical review of radiofrequency catheter ablation for cardiac arrhythmias. Can J Cardiol. 2003;19:1273-84.
64. Glass L, Hunter P, McCulloch A. Theory of heart: biomechanics, biophysics, and nonlinear dynamics of cardiac function. New York: Springer-Verlag; 1991.
65. Panfilov AV, Holden AV. Computational biology of the heart. Chichester-New York: Wiley; 1997.
66. Christini DJ, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ, Lerman BB. The role of nonlinear dynamics in cardiac arrhythmia control. Heart Dis. 1999;1:190-200.
67. Noble D. Modeling the heart - from genes to cells to the whole organ. Science. 2002;295:1678-82.
68. Engel G, Beckerman JG, Froelicher VF, Yamazaki T, Chen HA, Richardson K, McAuley RJ, Ashley EA, Chun S, Wang PJ. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol. 2004;29:365-432.
69. Pham Q, Quan KJ, Rosenbaum DS. T-wave alternans: marker, mechanism, and methodology for predicting sudden cardiac death. J Electrocardiol. 2003;36 Suppl:75-81.
70. Ritzenberg AL, Adam DR, Cohen RJ. Period multupling-evidence for nonlinear behaviour of the canine heart. Nature. 1984;307:159-61.
71. Adam DR, Smith JM, Akselrod S, Nyberg S, Powell AO, Cohen RJ. Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol. 1984;17:209-18.
72. Smith JM, Clancy EA, Valeri CR, Ruskin JN, Cohen RJ. Electrical alternans and cardiac electrical instability. Circulation. 1988;77:110-21.
73. Nearing BD, Huang AH, Verrier RL. Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science. 1991;252:437-40.
74. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330:235-41.
75. Hohnloser SH, Klingenheben T, Li YG, Zabel M, Peetermans J, Cohen RJ. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol. 1998;9:1258-68.
76. Armoundas AA, Osaka M, Mela T, Rosenbaum DS, Ruskin JN, Garan H, Cohen RJ. T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. Am J Cardiol. 1998;82:1127-9, A9.
77. Armoundas AA, Rosenbaum DS, Ruskin JN, Garan H, Cohen RJ. Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart. 1998;80:251-6.
78. Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, Estes NA, 3rd, Kaufman ES, Greenberg ML, Rosenbaum DS. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol. 2000;36:2247-53.
79. Narayan SM, Smith JM. Exploiting rate-related hysteresis in repolarization alternans to improve risk stratification for ventricular tachycardia. J Am Coll Cardiol. 2000;35:1485-92.
80. Narayan SM, Smith JM, Schechtman KB, Lindsay BD, Cain ME. T-wave alternans phase following ventricular extrasystoles predicts arrhythmia-free survival. Heart Rhythm. 2005;2:234-41.
81. Swygman CA, Homoud MK, Link MS, Wang PJ, Estes NA, 3rd. Technologic advances in implantable cardioverter defibrillators. Curr Opin Cardiol. 1999;14:9-14.
82. Rosenqvist M. Antitachycardia pacing: which patients and which methods? Am J Cardiol. 1996;78:92-7.
83. Glass L, Josephson ME. Resetting and annihilation of reentrant abnormally rapid heartbeat. Phys Rev Lett. 1995:2059-62.
84. Nomura T, Glass L. Entrainment and termination of reentrant wave propagation in a periodically stimulated ring of excitable media. Phys Rev E. 1996;53:6353-60.
85. Gonzalez H, Nagai Y, Bub G, Glass L, Shrier A. Resetting and annihilating reentrant waves in a ring of cardiac tissue: theory and experiment. Prog Theor Phys Supp. 2000:83-9.
86. Sinha S, Christini DJ. Termination of reentry in an inhomogeneous ring of model cardiac cells. Phys Rev E. 2002;66:061903.
87. Sinha S, Stein KM, Christini DJ. Critical role of inhomogeneities in pacing termination of cardiac reentry. Chaos. 2002;12:893-902.
88. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
89. Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C. Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol. 2001;12:134-42.
90. Swerdlow CD. Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: state-of-the-art review. J Cardiovasc Electrophysiol. 2001;12:606-12.
91. Ideker RE, Walcott GP, Epstein AE, Plumb VJ, Kay N. Ventricular fibrillation and defibrillation - what are the major unresolved issues? Heart Rhythm. 2005;2:555-8.
92. Walcott GP, Knisley SB, Zhou X, Newton JC, Ideker RE. On the mechanism of ventricular defibrillation. Pacing Clin Electrophysiol. 1997;20:422-31.
93. Trayanova NA. Are we closer to understanding defibrillation in the whole heart? J Cardiovasc Electrophysiol. 2002;13:1128-30.
94. Dillon SM, Gray RA. Ventricular fibrillation and defibrillation. In: Spooner PM, Rosen MR, editors. Foundations of cardiac arrhythmias: basic concepts and clinical approaches. New York: Marcel Dekker; 2001.
95. Ideker RE, Chattipakorn TN, Gray RA. Defibrillation mechanisms: the parable of the blind men and the elephant. J Cardiovasc Electrophysiol. 2000;11:1008-13.
96. Efimov IR, Nikolski VP, Salama G. Optical imaging of the heart. Circ Res. 2004;95:21-33.
97. Henriquez CS. Simulating the electrical behavior of cardiac tissue using the bidomain model. Crit Rev Biomed Eng. 1993;21:1-77.
98. Knisley SB, Hill BC, Ideker RE. Virtual electrode effects in myocardial fibers. Biophys J. 1994;66:719-28.
99. Sepulveda NG, Wikswo JP Jr. Bipolar stimulation of cardiac tissue using an anisotropic bidomain model. J Cardiovasc Electrophysiol. 1994;5:258-67.
100. Neunlist M, Tung L. Optical recordings of ventricular excitability of frog heart by an extracellular stimulating point electrode. Pacing Clin Electrophysiol. 1994;17:1641-54.
101. Wikswo JP Jr, Lin SF, Abbas RA. Virtual electrodes in cardiac tissue: a common mechanism for anodal and cathodal stimulation. Biophys J. 1995;69:2195-210.
102. Efimov IR, Cheng YN, Biermann M, Van Wagoner DR, Mazgalev TN, Tchou PJ. Transmembrane voltage changes produced by real and virtual electrodes during monophasic defibrillation shock delivered by an implantable electrode. J Cardiovasc Electrophysiol. 1997;8:1031-45.
103. Entcheva E, Eason J, Efimov IR, Cheng Y, Malkin R, Claydon F. Virtual electrode effects in transvenous defibrillation-modulation by structure and interface: evidence from bidomain simulations and optical mapping.J Cardiovasc Electrophysiol. 1998;9:949-61.
104. Efimov IR, Cheng Y, Van Wagoner DR, Mazgalev T, Tchou PJ. Virtual electrode-induced phase singularity: a basic mechanism of defibrillation failure. Circ Res. 1998;82:918-25.
105. Entcheva E, Trayanova NA, Claydon FJ. Patterns of and mechanisms for shock-induced polarization in the heart: a bidomain analysis. IEEE Trans Biomed Eng. 1999;46:260-70.
106. Cheng Y, Mowrey KA, Van Wagoner DR, Tchou PJ, Efimov IR. Virtual electrode-induced reexcitation: A mechanism of defibrillation. Circ Res. 1999;85:1056-66.
107. Trayanova N, Eason J. Shock-induced arrhythmogenesis in the myocardium. Chaos. 2002;12:962-72.
108. Trayanova NA, Gray RA, Bourn DW, Eason JC. Virtual electrode-induced positive and negative graded responses: new insights into fibrillation induction and defibrillation. J Cardiovasc Electrophysiol. 2003;14:756-63.
109. Trayanova N, Aguel F, Larson C, Haro C. Modeling cardiac defibrillation. In: Zipes DP, Jalife J, editors. Cardiac electrophysiology: from cell to bedside. 4th ed. Philadelphia: Saunders; 2004.
110. Gray RA, Chattipakorn N. Termination of spiral waves during cardiac fibrillation via shock-induced phase resetting. Proc Natl Acad Sci U S A. 2005;102:4672-7.
111. Chen PS, Wu TJ, Ting CT, Karagueuzian HS, Garfinkel A, Lin SF, Weiss JN. A tale of two fibrillations. Circulation. 2003;108:2298-303.
112. Trayanova NA, Eason JC, Aguel F. Computer simulations of cardiac defibrillation: a look inside the heart. Comput Visual Sci. 2002;4:259-70.
113. Tsai J, Cao JM, Zhou S, Swissa M, Cates AW, Kenknight BH, Chen LS, Karagueuzian HS, Chen PS. T wave alternans as a predictor of spontaneous ventricular tachycardia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol. 2002;13:51-5.
114. Armoundas AA, Albert CM, Cohen RJ, Mela T. Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. J Cardiovasc Electrophysiol. 2004;15:594-7.
115. Maybhate A, Hao SC, Iwai S, Lee JU, Guttigoli AB, Stein KM, Lerman BB, Christini DJ. Detection of repolarization with an implantable cardioverter defibrillator lead in a porcine model. IEEE Trans Biomed Eng. 2005;52:1188-94.
116. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation. 1998;98:1928-36.
117. Walker ML, Rosenbaum DS. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc Res. 2003;57:599-614.
118. Tachibana H, Kubota I, Yamaki M, Watanabe T, Tomoike H. Discordant S-T alternans contributes to formation of reentry: a possible mechanism of reperfusion arrhythmia. Am J Physiol. 1998;275:H116-21.
119. Chinushi M, Restivo M, Caref EB, El-Sherif N. Electrophysiological basis of arrhythmogenicity of QT/T alternans in the long-QT syndrome: tridimensional analysis of the kinetics of cardiac repolarization. Circ Res. 1998;83:614-28.
120. Shimizu W, Antzelevitch C. Cellular and ionic basis for T-wave alternans under long-QT conditions. Circulation. 1999;99:1499-507.
121. Pastore JM, Rosenbaum DS. Role of structural barriers in the mechanism of alternans-induced reentry. Circ Res. 2000;87:1157-63.
122. Fox JJ, Riccio ML, Hua F, Bodenschatz E, Gilmour RF Jr. Spatiotemporal transition to conduction block in canine ventricle. Circ Res. 2002;90:289-96.
123. Gronefeld G, Hohnloser SH. What do implantable cardioverter/ defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res. 2001;50:232-41.
124. Christini DJ, Stein KM, Markowitz SM, Mittal S, Slotwiner DJ, Scheiner MA, Iwai S, Lerman BB. Nonlinear-dynamical arrhythmia control in humans. Proc Natl Acad Sci U S A. 2001;98:5827-32.
125. Christini DJ, Glass L. Introduction: Mapping and control of complex cardiac arrhythmias. Chaos. 2002;12:732-9.
126. Garfinkel A, Spano ML, Ditto WL, Weiss JN. Controlling cardiac chaos. Science. 1992;257:1230-5.
127. Christini DJ, Collins JJ. Using chaos control and tracking to suppress a pathological nonchaotic rhythm in a cardiac model. Phys Rev E. 1996;53:R49-R52.
128. Watanabe M, Gilmour RF Jr. Strategy for control of complex low-dimensional dynamics in cardiac tissue. J Math Biol. 1996;35:73-87.
129. Hall K, Christini DJ, Tremblay M, Collins JJ, Glass L, Billette J. Dynamic control of cardiac alternans. Phys Rev Lett. 1997;78:4518-21.
130. Hall K, Christini DJ. Restricted feedback control of one-dimensional maps. Phys Rev E. 2001;63:046204.
131. Echebarria B, Karma A. Spatiotemporal control of cardiac alternans. Chaos. 2002;12:923-30.
132. Hall GM, Gauthier DJ. Experimental control of cardiac muscle alternans. Phys Rev Lett. 2002;88:198102.
133. Jordan PN, Christini DJ. Adaptive diastolic interval control of cardiac action potential duration alternans. J Cardiovasc Electrophysiol. 2004;15:1177-85.
134. Ott E, Grebogi C, Yorke JA. Controlling chaos. Phys Rev Lett. 1990;64:1196-9.
135. Rappel WJ, Fenton F, Karma A. Spatiotemporal control of wave instabilities in cardiac tissue. Phys Rev Lett. 1999;83:456-9.
136. Christini DJ, Riccio ML, Culianu CA, Fox JJ, Karma A, Gilmour RF Jr. Control of electrical alternans in canine cardiac Purkinje fibers. [Unpublished.]
137. Power JM, Raman J, Dornom A, Farish SJ, Burrell LM, Tonkin AM, Buxton B, Alferness CA. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res. 1999;44:549-55.
138. Oz MC, Konertz WF, Kleber FX, Mohr FW, Gummert JF, Ostermeyer J, Lass M, Raman J, Acker MA, Smedira N. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg. 2003;126:983-91.
139. Skanes AC, Yee R, Krahn AD, Klein GJ. Cryoablation of atrial arrhythmias. Card Electrophysiol Rev. 2002;6:383-8.
140. Keane D. New catheter ablation techniques for the treatment of cardiac arrhythmias. Card Electrophysiol Rev. 2002;6:341-8.
141. New approaches to antiarrhythmic therapy, Part II: emerging therapeutic applications of the cell biology of cardiac arrhythmias. Members of the Sicilian Gambit. Circulation. 2001;104:2990-4.
142. + conduction and selectivity. Science. 1998;280:69-77.
143. + channel. Nature. 2003;423:33-41.
144. Gilmour RF Jr. A novel approach to identifying antiarrhythmic drug targets. Drug Discov Today. 2003;8:162-7.
145. Karma A. Electrical alternans and spiral wave breakup in cardiac tissue. Chaos. 1994;4:461-72.
146. Courtemanche M. Complex spiral wave dynamics in a spatially distributed ionic model of cardiac electrical activity. Chaos. 1996;6:579-600.
147. Qu Z, Weiss JN, Garfinkel A. Cardiac electrical restitution properties and stability of reentrant spiral waves: a simulation study. Am J Physiol. 1999;276:H269-83.
148. Garfinkel A, Kim YH, Voroshilovsky O, Qu Z, Kil JR, Lee MH, Karagueuzian HS, Weiss JN, Chen PS. Preventing ventricular fibrillation by flattening cardiac restitution. Proc Natl Acad Sci U S A. 2000;97:6061-6.
149. Donahue JK. Gene therapy for cardiac arrhythmias. Ann N Y Acad Sci. 2004;1015:332-7.
150. Makkar RR, Lill M, Chen PS. Stem cell therapy for myocardial repair: is it arrhythmogenic? J Am Coll Cardiol. 2003;42:2070-2.
151. Lauer MR, Sung RJ. Anatomy and physiology of the conduction system. In: Podrid PJ, Kowey PR, editors. Cardiac arrhythmia: mechanisms, diagnosis, and management. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001.
152. Luo CH, Rudy Y. A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res. 1991;68:1501-26.
153. Fox JJ, McHarg JL, Gilmour RF Jr. Ionic mechanism of electrical alternans. Am J Physiol. 2002;282:H516-30.
154. Fenton F, Karma A. Vortex dynamics in three-dimensional continuous myocardium with fiber rotation: Filament instability and fibrillation. Chaos. 1998;8:20-47.
155. Beeler GW, Reuter H. Reconstruction of the action potential of ventricular myocardial fibres. J Physiol. 1977;268:177-210.